Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

30 mai 2018 09h10 HE | Source: Pfenex, Inc.

Pfenex to Present at the Jefferies 2018 Global Healthcare Conference

SAN DIEGO, May 30, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX) announced today that it will be presenting at the Jefferies 2018 Global Healthcare Conference in New York City. ...
29 mai 2018 09h10 HE | Source: Pfenex, Inc.

Pfenex Announces Closing of Public Offering of 7,820,000 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

SAN DIEGO, May 29, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
23 mai 2018 09h10 HE | Source: Pfenex, Inc.

Pfenex Announces Pricing of Offering of 6,800,000 Shares of Common Stock

SAN DIEGO, May 23, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...
22 mai 2018 16h23 HE | Source: Pfenex, Inc.

Pfenex Announces Offering of Common Stock

SAN DIEGO, May 22, 2018 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American:PFNX), a clinical-stage development and licensing biotechnology company focused on leveraging its Pfenex Expression Technology®...